Management of neutropenic enterocolitis in children with cancer

Nicklas Sundell1, Håkan Boström, Mats Edenholm

  • 1Department of Pediatrics, Institution of Clinical Sciences, Sahlgrenska University Hospital, Gothenburg, Sweden. nicklas.sundell@vgregion.se

Insights

Severe typhlitis in children with cancer can be effectively managed with conservative treatment including bowel rest and antibiotics. Early diagnosis through clinical suspicion and imaging is key to successful outcomes.

Area of Science:

  • Pediatric Oncology
  • Gastroenterology
  • Infectious Diseases

Background:

  • Typhlitis, also known as neutropenic enterocolitis, is a serious complication in pediatric oncology patients.
  • It is characterized by inflammation of the bowel wall, often associated with neutropenia and chemotherapy.

Purpose of the Study:

  • To detail the clinical presentation, management strategies, and short-term outcomes of severe typhlitis in pediatric cancer patients.
  • To identify predisposing factors and essential treatment components for typhlitis.

Main Methods:

  • Retrospective analysis of twelve typhlitis episodes in 11 children treated at a pediatric oncology ward (1995-2006).
  • Data collected included symptoms, radiological and laboratory findings, treatment interventions, and patient outcomes.

Main Results:

  • Classical signs included neutropenia, fever, abdominal pain, and bowel wall thickening.
  • All patients achieved successful outcomes with conservative management: bowel rest, broad-spectrum antibiotics, and supportive care.
  • Three patients required surgery for complications post-recovery.

Conclusions:

  • Early diagnosis is facilitated by high clinical suspicion and radiological imaging.
  • Hematologic malignancy and recent chemotherapy are significant predisposing factors.
  • Essential management involves supportive care, bowel rest (including parenteral nutrition), cytopenia correction, and aggressive antimicrobial therapy.
Abstract

Related Concept Videos

Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
Urinary Tract Infection IV: Nursing Management01:17

Urinary Tract Infection IV: Nursing Management

In managing urinary tract infections (UTIs) in nursing, a comprehensive assessment is essential. Begin by gathering subjective data, such as the patient’s complaints of dysuria (painful urination), urinary frequency, urgency, suprapubic pain, and any lower abdominal discomfort. This information can be complemented by questions regarding previous UTIs, sexual activity, and personal hygiene practices, which can provide insight into risk factors. Objective assessment should focus on signs like...
Peptic Ulcer Disease V: Surgical Management and Nursing Care01:25

Peptic Ulcer Disease V: Surgical Management and Nursing Care

Surgical management and nursing care are crucial in treating Peptic Ulcer Disease (PUD). Here is an organized and enhanced overview of the surgical interventions and the associated nursing care for PUD:
Surgical Interventions for Peptic Ulcer Disease
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates these...
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD: